Stay updated on IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.5.3 to v3.5.4, signaling a minor system/UI update to ClinicalTrials.gov. This change does not modify the study data or content visible on the page.
    Difference
    0.0%
    Check dated 2026-05-15T04:31:02.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    - The revision label on the page updated from v3.5.2 to v3.5.3, indicating a minor version update.
    Difference
    0.0%
    Check dated 2026-04-30T17:50:14.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T10:48:36.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Site revision metadata updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T18:03:26.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T14:35:07.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the prior Revision: v3.4.1 and a government funding lapse/operating status notice were removed.
    Difference
    0.4%
    Check dated 2026-02-11T09:22:12.000Z thumbnail image

Stay in the know with updates to IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMO-2125 Combo With Ipilimumab in Melanoma Clinical Trial page.